What makes sarcopenia during cancer treatment so difficult to prevent is that it is not a single problem with a single fix. Its development reflects interacting nutritional, inflammatory, metabolic, immune, behavioural, and functional disturbances, all unfolding against the backdrop of a demanding treatment schedule. In nasopharyngeal carcinoma, toxicities affecting oral intake, swallowing, and salivary function during radiotherapy compound these processes, driving progressive deterioration in nutritional status, physical activity, and daily functioning. Because risk and supportive care needs shift across the treatment trajectory, a preventive strategy that works in week one may be inadequate by week six. Yet current approaches remain fragmented, often delivered as isolated interventions targeting one aspect of care at a time. Nutritional supplementation, the most common strategy, plays an essential role in maintaining energy and protein intake, but interventions focused on nutrition alone may be insufficient to address the complex and evolving factors contributing to muscle loss during definitive treatment.

A research team led by Lijuan Xia of the General Hospital of Ningxia Medical University in China, working with colleagues including Naoko Hayashi of St. Luke’s International University in Tokyo, has now tackled this gap head-on. Writing in the journal Supportive Care in Cancer, they report the development of a context-sensitive supportive care pathway designed to coordinate multidisciplinary sarcopenia prevention across the entire nasopharyngeal carcinoma treatment trajectory. Crucially, the study does not claim to prove that the pathway works. Instead, its contribution lies in providing a transparent, theoretically informed account of how such a pathway should be built, drawing together evidence, theory, stakeholder perspectives, and real-world constraints before any effectiveness testing begins. The work was guided by the updated Medical Research Council framework for developing and evaluating complex interventions, a methodological blueprint that emphasises integrating multiple sources of knowledge through iterative refinement.

The development process was anchored by a multidisciplinary team of thirteen healthcare professionals: four physicians, four nurses, two dietitians, one physiotherapist, one clinical pharmacist, and one psychologist, each with at least fifteen years of professional experience and senior rank in their discipline. This team served as the core decision-making body, appraising candidate components, adapting them to local conditions, and finalising the operational structure across two formal face-to-face meetings held in February and March 2025. Foundational inputs came from five complementary activities: a systematic review of non-pharmacological interventions, semi-structured interviews with healthcare professionals, economic and resource considerations, programme theory development, and contextual analysis. The systematic review included 21 randomised controlled trials reported in 22 publications, all conducted in China, and revealed a strikingly uneven evidence base. Evidence was most extensive for nutritional interventions, while exercise and probiotic approaches were supported by fewer, more heterogeneous studies.

The qualitative component provided the implementation intelligence that evidence alone cannot supply. Of 26 healthcare professionals invited, 21 participated in interviews conducted between January and February 2025, spanning five physicians, seven nurses, three dietitians, two physiotherapists, two clinical pharmacists, and two psychologists. Reflexive thematic analysis, informed by the Theoretical Domains Framework as a sensitising lens, generated three overarching themes comprising eleven subthemes: knowledge and competency gaps, structural and implementation barriers, and key intervention suggestions. Participants described limited recognition of sarcopenia, unclear professional responsibilities, and fragmented multidisciplinary care. For pathway development, these findings were synthesised into four cross-cutting implementation requirements: recognition and professional competency, care organisation and multidisciplinary coordination, longitudinal monitoring and continuity of care, and patient self-management and family-supported care. Each requirement was mapped directly to a design response in the final pathway, creating an auditable link between what clinicians said was missing and what the pathway delivers.

Resource realities shaped several pragmatic decisions. Routine vitamin D supplementation was not adopted; it was restricted to patients with documented deficiency, following locally approved laboratory and clinical procedures. Probiotic support was retained as a context-adaptable rather than universally fixed component, because the formulations evaluated in nasopharyngeal carcinoma trials were not fully matched by locally available products, and similar products had limited routine affordability. Repeated specialised immunological testing was judged too resource-intensive for routine longitudinal care, so the team instead selected pragmatic supplementary monitoring measures derived from routinely collected clinical parameters, including the global immune-nutrition-inflammation index, the HALP score combining hemoglobin, albumin, lymphocyte, and platelet counts, and the prognostic nutritional index. These indices were not used as standalone diagnostic thresholds; their trends were interpreted alongside body weight, oral intake, symptoms, and treatment tolerance to inform reassessment and escalation decisions.

The final pathway rests on three interconnected structural elements. First, it specifies discipline-specific roles within a coordinated multidisciplinary workflow: physicians oversee clinical assessment and medical management, nurses conduct comprehensive assessment and education while coordinating communication, dietitians adjust individualised nutritional plans, physiotherapists assess function and guide safe activity, psychologists manage distress and support behavioural adaptation, and clinical pharmacists support symptom and medication management. Second, it defines six longitudinal care procedures: assessment and individualised planning, one-to-one education, weekly monitoring, multidisciplinary consultation for complex or escalating needs, scheduled multidisciplinary reassessment at key treatment time points, and an end-of-treatment review with a care summary. Third, it organises supportive care into five strategic domains: nutritional and immune management, exercise management, head and neck symptom cluster management, gastrointestinal symptom cluster management, and psycho-behavioural support.

Two operational features deserve particular attention. The pathway embeds a risk stratification system based on the 2019 Asian Working Group for Sarcopenia criteria, using bioelectrical impedance analysis to measure appendicular skeletal muscle mass index, handgrip strength, and six-metre gait speed. Low muscle mass with preserved strength and performance is treated as a pathway-level early-warning state, while body-weight losses of 2.5 percent and 5 percent from baseline serve as pragmatic triggers for early multidisciplinary review and further escalation of support respectively. The team is careful to note these thresholds are pathway triggers, not universally validated diagnostic cut-offs. Meanwhile, the psycho-behavioural domain is grounded in the theory of planned behaviour: education, goal setting, tailored feedback, and family reinforcement are designed to strengthen patients’ attitudes, perceived social norms, and sense of behavioural control, which in turn are hypothesised to improve adherence to nutritional, exercise, and symptom-management recommendations and ultimately preserve muscle mass, strength, and function.

Patient and family voices entered the process through informal consultations with six patients undergoing or recently completing definitive treatment and six family caregivers. Most participants were initially unfamiliar with the term sarcopenia and, after explanation by nursing staff, tended to relate it to the more familiar concept of malnutrition. Their feedback centred on practical needs, particularly nutritional support, physical activity, home-based self-management, and family involvement, and informed refinements to one-to-one education and caregiver engagement. The researchers are candid about limitations: the study did not evaluate feasibility or effectiveness, the evidence base for individual components was uneven, development was situated within the Chinese healthcare context, and patient involvement was consultative rather than a formal co-development partnership. A pilot randomised controlled trial protocol has since been published to operationalise the pathway for feasibility testing. The team’s central message stands: sarcopenia prevention during cancer treatment should be conceived not as a series of isolated interventions, but as a coordinated, longitudinal, multidisciplinary process, one that treats prevention as dynamic risk management rather than episodic repair.

Subject of Research: Development of a multidisciplinary supportive care pathway for sarcopenia prevention in patients with nasopharyngeal carcinoma undergoing definitive treatment

Article Title: Developing a supportive care pathway for sarcopenia prevention in nasopharyngeal carcinoma: a context-sensitive and implementation-oriented approach

Article References: Xia, L., Chen, S., Min, J., Ma, Z., Zhang, Y., Zhang, F., Liu, S., Yan, B., & Hayashi, N. (2026). Developing a supportive care pathway for sarcopenia prevention in nasopharyngeal carcinoma: a context-sensitive and implementation-oriented approach. Supportive Care in Cancer, 34(10), Article 1058. https://doi.org/10.1007/s00520-026-11242-4

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11242-4

Keywords: sarcopenia, nasopharyngeal carcinoma, supportive care, multidisciplinary care, cancer nutrition, exercise oncology, implementation science, Medical Research Council framework, chemoradiotherapy, patient self-management, symptom management, complex interventions

The study, led by Mildred Visser of the Erasmus School of Health Policy & Management at Erasmus University Rotterdam, followed a two-year care pathway development programme conducted in a Dutch specialized rehabilitation hospital with sixteen sites. Eleven multidisciplinary teams worked in parallel to design care pathways for different patient populations, guided by five quality improvement principles: collaborative improvement, stepwise and goal-oriented pathway development, hybrid development that combines design with learning, outcome monitoring, and shared ownership among participants. Rather than treating the programme as a fixed protocol to be evaluated at the end, the researchers embedded themselves in it, documenting how it unfolded, where it strained, and how it had to be reshaped in response to events on the ground.

The choice of action research as the guiding methodology is central to the paper’s argument. Action research differs from conventional observational research in that the researcher participates in the change process itself, generating scientific knowledge through cycles of planning, action, observation and reflection. In this programme, the research team collected reflexive data continuously: 169 journal reports, 44 recorded conversations with team members and senior managers, 25 research team meetings, and 149 programme documents. The data were analysed in four iterative phases, combining elements of process analysis and reflexive thematic analysis, so that insights from one cycle could inform adjustments in the next. This created a feedback loop between the programme and its own evaluation, which proved essential when the original design assumptions collided with practical constraints.

What emerged from the analysis were six distinct challenges that arose when multiple care pathways were developed in parallel. The first concerned alignment: teams differed in their pace of progress, their learning needs and their clinical scope, and the standardized programme structure did not always fit these differences. Teams working on complex conditions such as spinal cord injury rehabilitation faced different design questions than teams focused on other rehabilitation populations, and forcing everyone through identical steps at identical speeds created friction. The programme had to be refined repeatedly to allow teams to move at appropriate speeds while still benefiting from shared learning across the collaborative.

The second challenge was balancing innovation with manageable change. Teams were encouraged to redesign care in meaningful ways, but too much change at once threatened to overwhelm frontline staff and disrupt daily operations. The researchers found that the programme’s design had implicitly assumed a capacity for change that the organization did not always possess, and adjustments were needed to pace the innovations so that they remained implementable. Closely related was the third challenge: the organization’s limited readiness for hybrid care, in which treatment is delivered through a mix of in-person and remote modalities. The pandemic era accelerated interest in hybrid care models, but embedding them into formal care pathways required infrastructure, skills and cultural acceptance that could not be assumed in advance.

The fourth challenge involved outcome monitoring, a cornerstone of value-based care. Teams were expected to measure patient outcomes systematically, but the study revealed practical problems in doing so, including difficulties with data collection and a heavy reliance on expert support to make measurement meaningful. Without functioning outcome monitoring, the feedback that was supposed to drive improvement weakened. The fifth challenge concerned distributed leadership and capability development. Because eleven teams were working simultaneously, leadership could not be concentrated in a single group; the programme had to cultivate improvement capabilities across the organization, which took time and deliberate investment. The sixth challenge was reflexive in nature: the programme itself was hybrid, combining fixed design elements with ongoing learning and adaptation, and teams needed help navigating that ambiguity.

Each of these challenges, the authors argue, exposed assumptions embedded in the original programme design that were tested and often overturned in practice. Crucially, the action research approach allowed those assumptions to be surfaced and corrected in real time rather than discovered only in a post-hoc evaluation, when it would have been too late to help. Successive refinements to the programme were documented and analysed as part of the research itself, turning the inevitable turbulence of organizational change into a source of scientific insight. The researchers describe this as linking change, learning and knowledge generation in a single continuous process, which is precisely what conventional quality improvement collaboratives often fail to achieve.

The implications reach beyond this single Dutch hospital. Care pathway development is a global strategy in value-based healthcare, and organizations everywhere struggle with the same tension between standardization and local adaptation. The study’s conclusion is that action research offers a feasible methodology for implementing and adapting care pathway development methods through phased, reflective and context-sensitive learning. By embedding reflection and adaptation into the programme from the start, action research helped balance structure with flexibility, strengthened shared ownership among clinicians and managers, and integrated sustainability considerations early in the process rather than as an afterthought. In other words, the methodology did not just measure whether the programme worked; it actively helped the programme work.

The research also carries a message about patient involvement. The programme included patient representatives, including two from a post-discharge spinal cord injury rehabilitation network and one from multiple sclerosis rehabilitation, who participated as partners in the pathway design process and helped ground the designs in lived experience. This participatory element aligns with the collaborative improvement principle and reflects a broader shift in health services research toward co-design with the people who actually use the services. Combined with the study’s rigorous documentation of its own methods, including a published coding structure mapping data to the five quality improvement principles and adherence to recognized qualitative reporting standards, the work offers a template that other organizations can adapt.

Funded by the Dutch Organisation for Health Research and Development, ZonMw, the study arrives at a moment when health systems face accelerating pressure from aging populations, workforce shortages and technological change, all of which make rigid, one-size-fits-all improvement programmes increasingly untenable. The authors’ central finding is deceptively simple: care pathway methods describe what good pathways should contain, but only a methodology that embraces reflection, participation and continuous adaptation can bridge the gap between those methods and their practical application. Action research, demonstrated here across two years, eleven teams and sixteen sites, appears to be that bridge. For hospital leaders contemplating large-scale pathway programmes, the lesson is that the process of development matters as much as the product, and that building flexibility into the process from day one may be the difference between pathways that endure and pathways that quietly fade from use.

Subject of Research: Using action research to guide parallel, adaptive care pathway development in a dynamic hospital organization

Article Title: Action research as a methodology for adaptive care pathway development in a dynamic organizational context

Article References: Visser, M., de Mul, M., Ahaus, K., Osterthun, R., Pangalila, R., Grauwmeijer, E., Sluijter, A., van Pelt-Zoutendijk, M., & Weggelaar-Jansen, A. M. (2026). Action research as a methodology for adaptive care pathway development in a dynamic organizational context. Health Research Policy and Systems. https://doi.org/10.1186/s12961-026-01520-2

Image Credits: AI Generated

DOI: 10.1186/s12961-026-01520-2

Keywords: action research, care pathways, care pathway development, quality improvement, rehabilitation medicine, hybrid care, outcome monitoring, participatory methods, health services research, complex interventions, healthcare innovation, qualitative research